Skip to main content
Equibles

LKFT · Lakefront Biotherapeutics NV · Short Interest

Track LKFT — free

Use LKFT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LKFT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$32.28 -0.05 (-0.15%) At close · Oct 30 Q1 2026 earnings call transcript
Rebalance outlook locked
Market Cap
$2.13B
Shares
65.90M
Volume · Oct 30 164.06K Avg daily vol (3M) 283.93K

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

Pull short interest history through the short interest API or MCP →

LKFT Latest Reported Short Interest

FINRA reported 1,416,118 LKFT shares sold short as of the October 15, 2026 settlement date, a decrease of 1,901,833 shares. Days to cover was 4.77 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

LKFT Short Interest Forecast

Equibles' model estimates 1,392,164 shares sold short for the October 30, 2026 settlement, -1.7% versus the latest reported position, with a likely range of 1,102,180 to 1,685,026 shares. This model prediction uses FINRA data through October 30, 2026; FINRA's official release is expected November 10, 2026.

Model estimate

Expected Oct 30 short interest

as of Oct 30 Low confidence 63% chance it falls
1,392,164 -1.7% vs reported
Likely range 1,102,180 to 1,685,026 The latest estimate appears in the chart below. Official release expected Nov 10. Methodology
Short Squeeze Score
53/100
Short interest 2.1% of shares — P50 Days to cover 4.8 — P64 Price vs VWAP +11.3% — P93 Short-volume trend +1.6% — P58 Short interest change -57.3% — P4 Worst FTD 0.00% of shares — P27

Positioning score 53.4 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-10-15). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

Open interest is incomplete, stale, or dated inconsistently; positioning totals are unavailable.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-11-02 09:50 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Interest History

    Settlement Date Current Position Previous Position Change Days to Cover
    2026-11-13 Scheduled
    FINRA publishes Nov 24
    		 — — — —
    2026-10-30 Scheduled
    FINRA publishes Nov 10
    		 — — — —
    2026-10-15 1,416,118 3,317,951 -1,901,833 4.77
    2026-09-30 3,317,951 3,413,512 -95,561 9.48
    2026-09-15 3,413,512 3,295,220 +118,292 12.35
    2026-08-31 3,295,220 2,972,977 +322,243 14.00
    2026-08-14 2,972,977 2,521,939 +451,038 10.17
    2026-07-31 2,521,939 2,323,166 +198,773 14.05
    2026-07-15 2,323,166 2,238,240 +84,926 16.15
    2026-06-30 2,238,240 2,183,405 +54,835 15.81
    2026-06-15 2,183,405 1,871,825 +311,580 9.67
    2026-05-29 1,871,825 1,602,902 +268,923 13.32
    2026-05-15 1,602,902 1,435,699 +167,203 9.39
    2026-04-30 1,435,699 1,371,531 +64,168 11.17
    2026-04-15 1,371,531 1,096,114 +275,417 8.53
    2026-03-31 1,096,114 910,692 +185,422 5.02
    2026-03-13 910,692 794,191 +116,501 6.68
    2026-02-27 794,191 752,266 +41,925 7.79
    2026-02-13 752,266 758,655 -6,389 9.12
    2026-01-30 758,655 928,021 -169,366 6.81
    2026-01-15 928,021 988,368 -60,347 7.00
    2025-12-31 988,368 968,832 +19,536 11.25
    2025-12-15 968,832 1,041,945 -73,113 11.26
    2025-11-28 1,041,945 1,000,709 +41,236 9.59
    2025-11-14 1,000,709 1,679,024 -678,315 5.57

    Full FINRA short interest reporting calendar

    Showing 1–23 of 23 settlements
    Key facts CIK 1421876 CUSIP 36315X101 13F (30d) 14 filings 14 filers Visit website Investor relations